Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,024 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $253.50 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $161.69 | 8 | $0 (2024) |
| ABBVIE INC. | $158.28 | 12 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $102.40 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $71.87 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $56.33 | 3 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $42.46 | 2 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $37.63 | 2 | $0 (2024) |
| Lundbeck LLC | $35.04 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $21.90 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $366.14 | 17 | Otsuka America Pharmaceutical, Inc. ($88.29) |
| 2023 | $203.63 | 5 | Alkermes, Inc. ($158.10) |
| 2022 | $256.16 | 17 | ABBVIE INC. ($125.40) |
| 2021 | $197.57 | 12 | Otsuka America Pharmaceutical, Inc. ($36.82) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: CNS | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Neuropsychiatry | ||||||
| 09/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: CNS | ||||||
| 09/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: CNS | ||||||
| 10/19/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: CNS | ||||||
| 09/29/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Neuroscience | ||||||
| 03/13/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: CNS | ||||||
| 03/01/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: CNS | ||||||
| 07/19/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Neuroscience | ||||||
| 07/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 91 | $35,251 | $6,834 |
| 2021 | 3 | 47 | 47 | $8,905 | $4,018 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 77 | $20,717 | $5,079 | 24.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 14 | $14,535 | $1,755 | 12.1% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 18 | 18 | $4,590 | $2,058 | 44.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 11 | 11 | $3,685 | $1,484 | 40.3% |
| 96136 | Psychological or neuropsychological test administration and scoring by qualified health care professional, first 30 minutes | Office | 2021 | 18 | 18 | $630.00 | $476.00 | 75.6% |
About Suzanne Swain, FNP-BC
Suzanne Swain, FNP-BC is a Psychiatric/Mental Health healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1790245678.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Suzanne Swain, FNP-BC has received a total of $1,024 in payments from pharmaceutical and medical device companies, with $366.14 received in 2024. These payments were reported across 51 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,024).
As a Medicare-enrolled provider, Swain has provided services to 86 Medicare beneficiaries, totaling 138 services with total Medicare billing of $10,852. Data is available for 2 years (2021–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Scottsdale, AZ
- Active Since 03/25/2019
- Last Updated 08/19/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1790245678
Products in Payments
- ARISTADA (Drug) $253.50
- REXULTI (Drug) $183.40
- VRAYLAR (Drug) $158.28
- INGREZZA (Drug) $71.87
- CAPLYTA (Drug) $61.57
- INVEGA SUSTENNA (Drug) $59.82
- TRINTELLIX (Drug) $56.33
- SPRAVATO (Drug) $42.58
- HETLIOZ (Drug) $37.63
- Auvelity (Drug) $21.90
- APLENZIN (Drug) $17.42
- Nuedexta (Drug) $16.78
- Dayvigo (Drug) $15.36
- AUSTEDO (Drug) $13.73
- ABILIFY MYCITE (Drug) $13.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Scottsdale
Mr. Brett Leifson, Aprn Msn Pmhnp-Bc, APRN MSN PMHNP-BC
Psychiatric/Mental Health — Payments: $72,825
Chyllia Dixon, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $5,973
Susan Bowen, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $5,493
Denise Drake, Nurse Practitioner, NURSE PRACTITIONER
Psychiatric/Mental Health — Payments: $5,248
Ms. Kathe Reitman, Pmhnp, Bc, PMHNP, BC
Psychiatric/Mental Health — Payments: $5,035
Mary Fisher Pinson, Np, NP
Psychiatric/Mental Health — Payments: $2,882